Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating sofobuvir/ledipasvir with or without ribavirin in cirrhotic patients with chronic genotype 1 hepatitis C virus infection; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir/Ledipasvir (sofosbuvir/ledipasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: HCV Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-09-28